Statewide market context
See the market
behind the storefronts.
Delaware’s public market data helps explain the category mix and direction of the market. It does not reveal how much any individual dispensary sells.
Latest complete monthly series reviewed · October 2026 · NCS Transparency Project
Read the denominator carefullyNCS’s “Total Reported Sales Analyzed” combines reported sales, including retail transactions and wholesale purchases where provided. The table below separates Adult Use, Medicinal and Wholesale. It is not a store-by-store ranking or a pure checkout-revenue measure.
May 2026$3.37MAdult-use reported sales analyzed
Jun 2026$4.77MAdult-use reported sales analyzed
Jul 2026$5.61MAdult-use reported sales analyzed
Aug 2026$5.58MAdult-use reported sales analyzed
Sep 2026$5.61MAdult-use reported sales analyzed
Oct 2026$6.19MAdult-use reported sales analyzed
The following breakdown uses the Adult Use category chart on the NCS Transparency Project. Values are rounded to the nearest dollar in the source. Product-category shares describe reported statewide sales, not the menu breadth or quality of any operator.
Flower and inhalable extracts account for the largest shares of October 2026 adult-use retail sales in the NCS dataset. Solid infused edibles are a smaller share. These are market-level signals only: they do not prove that one location carries more categories, has better selection, or offers lower prices than another.
The public dataset aggregates and does not disclose confidential licensee information. We therefore do not estimate store-level sales, market share by operator, average price by store or “top-selling dispensary” rankings.